GL1X · GenesisL1 explorer

Research workbench

Crystal structure of an extracellular domain fragment of human baff

Analyse Crystal structure of an extracellular domain fragment of human baff in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1KD7
Type
protein
Length
864 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tumor necrosis factor ligand superfamily member 13B
UniProt
Q9Y275
Pockets
11 · best druggability 0.51

Structure

x-ray diffraction · 1 distinct chain · 0% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, K, L, MTumor necrosis factor ligand superfamily member 13Bprotein1440% helix, 53% strandQ9Y275

Pockets

11 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11740.510.7826empty
21600.480.7724empty
31230.410.7519empty
41110.410.7517empty
5960.390.7617empty

Interfaces

6 interfaces between chains.

  • L–M · 986 Ų buried · 23 hydrogen bonds · protein-protein
  • K–M · 984 Ų buried · 24 hydrogen bonds · protein-protein
  • A–B · 978 Ų buried · 23 hydrogen bonds · protein-protein
  • A–C · 977 Ų buried · 23 hydrogen bonds · protein-protein
  • K–L · 976 Ų buried · 20 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 1KD7 · Crystal structure of an extracellular domain fragment of human BAFF · the same entry in another collection · chain C against C, TM-score 1.00
  • Q9Y275 · AlphaFold monomer V2.0 prediction for tumor necrosis factor ligand superfamily member 13B… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.